Amit Munshi Net Worth

The estimated Net Worth of Amit Munshi is at least 14.8 百万$ dollars as of 16 August 2021. Mr. Munshi owns over 1,000 units of Arena Pharmaceuticals Inc stock worth over 3,954,605$ and over the last 9 years he sold ARNA stock worth over 1,930,200$. In addition, he makes 8,931,400$ as Director、 President and Chief Executive Officer at Arena Pharmaceuticals Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Munshi ARNA stock SEC Form 4 insiders trading

Amit has made over 16 trades of the Arena Pharmaceuticals Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of ARNA stock worth 48,190$ on 16 August 2021.

The largest trade he's ever made was exercising 100,000 units of Arena Pharmaceuticals Inc stock on 15 January 2021 worth over 1,550,000$. On average, Amit trades about 15,809 units every 45 days since 2016. As of 16 August 2021 he still owns at least 39,550 units of Arena Pharmaceuticals Inc stock.

You can see the complete history of Mr. Munshi stock trades at the bottom of the page.

Amit Munshi biography

Amit D. Munshi serves as Director, President and Chief Executive Officer of the Company. He has served as a member of our Board of Directors since June 2016, and as our President and Chief Executive Officer since May 2016. Previously, Mr. Munshi served as President and Chief Executive Officer and a director of Epirus Biopharmaceuticals, Inc. from May 2012 to May 2016, and as Chief Executive Officer of Percivia LLC, a biotechnology company, from 2011 to 2012. Prior to Epirus and Percivia, Mr. Munshi was a co-founder and served as Chief Business Officer of Kythera Biopharmaceuticals, Inc., from 2005 to 2010, and held multiple leadership positions at Amgen Inc. from 1997 to 2005, including General Manager, Nephrology Europe. In July 2016, Epirus filed a voluntary Chapter 7 petition in the United States Bankruptcy Court for the District of Massachusetts. Mr. Munshi holds a B.S. in Economics and a B.A. in History from the University of California, Riverside, and an M.B.A. from the Peter F. Drucker School of Management at Claremont Graduate University. Mr. Munshi has more than 28 years of global biopharmaceutical industry experience in executive management, business development, product development and portfolio management. Mr. Munshi currently serves on the board of Pulmatrix, Inc., a biopharmaceutical company developing inhaled therapies to address pulmonary diseases, and also serves as an advisor and lecturer at the Peter F. Drucker School of Management at the Claremont Graduate School.

What is the salary of Amit Munshi?

As the Director、 President and Chief Executive Officer of Arena Pharmaceuticals Inc, the total compensation of Amit Munshi at Arena Pharmaceuticals Inc is 8,931,400$. There are no executives at Arena Pharmaceuticals Inc getting paid more.

What's Amit Munshi's mailing address?

Amit's mailing address filed with the SEC is OLE MAALOES VEJ 3, C/O GALECTO, INC., COPENHAGEN N G7, G7, DK-2200.

Insiders trading at Arena Pharmaceuticals Inc

Over the last 21 years, insiders at Arena Pharmaceuticals Inc have traded over 9,243,184$ worth of Arena Pharmaceuticals Inc stock and bought 78,040 units worth 252,505$ . The most active insiders traders include Partners L P/Ilbiotechnolog...、Manmeet Singh Soni、Garry Arthur Neil. On average, Arena Pharmaceuticals Inc executives and independent directors trade stock every 39 days with the average trade being worth of 3,133,387$. The most recent stock trade was executed by Amit Munshi on 16 August 2021, trading 1,000 units of ARNA stock currently worth 48,190$.

What does Arena Pharmaceuticals Inc do?

Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas

Complete history of Mr. Munshi stock trades at Arena Pharmaceuticals Inc、Pulmatrix Inc、Galecto

Arena Pharmaceuticals Inc executives and stock owners

Arena Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Amit Munshi,
  Director, President and Chief Executive Officer
• Vincent Aurentz,
  Executive Vice President and Chief Business Officer
• Robert Lisicki,
  Executive Vice President and Chief Commercial Officer
• Amit D. Munshi M.B.A.,
  Pres, CEO & Director
• Vincent E. Aurentz,
  Exec. VP & Chief Bus. Officer
• Dr. Christopher H. Cabell FACC, M.D., MHS,
  Advisor
• Laurie D. Stelzer,
  Exec. VP & CFO
• Joan Schmidt,
  Exec. VP, Gen. Counsel & Sec.
• Tina Nova,
  Independent Chairman of the Board
• Jennifer Jarrett,
  Independent Director
• Randall Woods,
  Independent Director
• Jayson Dallas,
  Independent Director
• Manmeet Soni,
  Independent Director
• Kieran Gallahue,
  Independent Director
• Oliver Fetzer,
  Independent Director
• Garry Neil,
  Independent Director
• Katharine Knobil,
  Director
• Joan Schmidt,
  Executive Vice President, General Counsel, Secretary
• Laurie Stelzer,
  Chief Financial Officer, Executive Vice President
• Patrick Malloy,
  VP of Investor Relations & Corp. Communications
• Megan E. Knight,
  Director of Investor Relations
• Dr. Lamine Mbow Ph.D.,
  Sr. VP & Chief Scientific Officer
• Dr. Douglas A. Bakan Ph.D.,
  Exec. VP of Technical Operations
• Harry F Jr Hixson,
  Director
• Maurice James Mezzino,
  SVP, Corporate Development
• Phillip M Schneider,
  Director
• Preston Klassen,
  EVP and CMO
• Steven W Spector,
  EVP, General Counsel & Sec
• Scott H Bice,
  Director
• Kevin Robert Lind,
  Executive VP and CFO
• Christine Anna White,
  Director
• Donald D Belcher,
  Director
• Nawal Ouzren,
  Director
• Frederick Frank,
  
• Mark N Lampert,
  Director
• Robert Hoffman,
  SVP, Finance and CFO
• Partners L P/Ilbiotechnolog...,
  
• James Laforce,
  Director
• Jennifer Kathleen Bielasz,
  VP, Accounting & Controller
• K A Ajit Simh,
  VP, Quality Systems
• Jack Lief,
  Chairman, President and CEO
• Craig Michael Audet,
  SVP, Opn & Head Glob Reg Afrs
• Duke K Bristow,
  Director
• Robert L Toms,
  Director
• Paul W Maffuid,
  VP, Pharmaceutical Development
• Joyce H Williams,
  VP, Drug Development
• Partners L P/Ilbvf Inc/Ilbi...,
  
• Nigel R A Beeley,
  VP, Chief Chemical Officer
• Joseph F Mooney,
  Chief Financial Officer
• Derek T Chalmers,
  Vice President, Research
• Louis J Scotti,
  VP, Marketing and Bus Dev
• Dominic P Behan,
  EVP & Chief Scientific Officer
• James Edeerfield Capital Lp...,
  
• Louis J Jr Lavigne,
  Director
• William R Jr Shanahan,
  SVP & Chief Medical Officer
• Christopher Cabell,
  EVP, Head of R&D, and CMO
• Steven J Schoch,
  Director
• Douglas J. Manion,
  EVP Research & Development